Efficacy and safety of subcutaneous administration of lyophilized powder of alfa-erythropoietin to maintain hemoglobin concentrations among hemodialysis patients

BACKGROUND: Anemia associated with chronic kidney disease (CKD) often requires treatment with recombinant human erythropoietin (EPO). This study investigated the therapeutic equivalence between lyophilized powder and standard liquid EPO alfa by subcutaneous (SC) administration in hemoglobin maintena...

Descripción completa

Detalles Bibliográficos
Autores principales: Satirapoj, Bancha, Dispan, Rattanawan, Supasyndh, Ouppatham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614773/
https://www.ncbi.nlm.nih.gov/pubmed/29033600
http://dx.doi.org/10.2147/IJNRD.S143731

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614773/
https://www.ncbi.nlm.nih.gov/pubmed/29033600
http://dx.doi.org/10.2147/IJNRD.S143731

Ejemplares similares